Kamagra Export 100 mg Tablets - Sildenafil Citrate

Product Description

Kamagra Export 100 mg Tablets are listed as an allopathic pharmaceutical product containing sildenafil citrate as the active ingredient. According to the supplied product information, the medicine is presented in tablet form and packaged in a box containing four tablets. The product is associated with the sildenafil category of medicines used in the management of erectile dysfunction, subject to appropriate medical supervision and applicable regulatory requirements. **Composition and Formulation** The supplier identifies sildenafil citrate as the composition and tablet as the dosage form. The product name specifies 100 mg strength. However, the supplied information does not separately confirm the strength per tablet through a verified label or manufacturer document. Buyers should check the original packaging and approved product information to confirm the active ingredient, strength, excipients and dosage instructions. Sildenafil belongs to the phosphodiesterase type 5 (PDE5) inhibitor class of medicines. It works by influencing the nitric oxide and cyclic guanosine monophosphate pathway, helping support blood flow in penile tissue during sexual stimulation. This is general information about sildenafil's pharmacological class and does not independently establish the quality, safety, effectiveness or authorization of this specific product. **Packaging and Product Specifications** The supplied listing identifies the packaging type as a box, with a pack configuration of 1 × 4 tablets. The stated shelf life is 24 months. The product is listed under the Kamagra brand, with Ajanta Pharma named as the manufacturer and India specified as the country of origin. These details are supplier-provided and require verification against authentic packaging and manufacturer documentation. **Procurement Information** Pharmaceutical wholesalers, distributors and other eligible business buyers should confirm the available batch, pack configuration, expiry date, storage conditions and accompanying documentation before procurement. The supplier listing identifies clinic use as the usage application and classifies the medicine as allopathic. These catalogue fields should not be interpreted as confirmation of institutional suitability or regulatory approval. **Safety and Regulatory Considerations** Sildenafil may interact with nitrate-containing medicines and can cause a dangerous decrease in blood pressure. It may also interact with certain other medicines, making professional medical assessment important before use. Patients should follow the advice of a qualified healthcare professional and the instructions provided with an appropriately authorized product. Chest pain, sudden vision or hearing changes, or an erection lasting more than four hours require urgent medical attention. Before publishing or purchasing Kamagra Export 100 mg Tablets, verify the product's authenticity, manufacturer identity, actual strength, batch details, expiry date, storage instructions and regulatory authorization in the intended market. The supplied information does not establish independent verification of these details or confirm authorization for sale in India.

Additional Product Details

No additional product details available.

Product Specifications

Business Information